Plavan Matthew T 4
4 · Arcadia Biosciences, Inc. · Filed Jan 25, 2021
Insider Transaction Report
Form 4
Plavan Matthew T
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-21+250,000→ 435,450 totalExercise: $3.05Exp: 2031-01-21→ Common Stock (250,000 underlying) - Purchase
Common Stock
2020-08-03$3.16/sh+585$1,849→ 14,285 total
Footnotes (2)
- [F1]Reflects the purchase of 585 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.
- [F2]The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service.